Leo builds dermatology pipeline with Timber deal
pharmaphorum
AUGUST 23, 2023
Leo builds dermatology pipeline with Timber deal Phil.Taylor Wed, 23/08/2023 - 08:40 Bookmark this
Dermatology Related Topics 
Optimizing Endpoint Assessments for Dermatology Studies
WCG Clinical
SEPTEMBER 20, 2023
Welcome to the recorded session of ‘Optimizing Endpoint Assessments for Dermatology Studies.’ In this insightful webinar, we take a deep dive into dermatology trials and discuss how standardizing rater qualification and training can solve common challenges and protect the quality and integrity of endpoint data.
Dermatology 
52
52 Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game
pharmaphorum
AUGUST 11, 2023
Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game Mike.Hammerton Fri, 11/08/2023 - 08:00 Bookmark this
Dermatology 98
98 
LEO Pharma enhances dermatology pipeline with Timber Pharmaceuticals takeover
BioPharma Reporter
AUGUST 22, 2023
LEO Pharma has acquired Timber Pharmaceuticals, in a deal that will add an âattractiveâ late stage asset to its pipeline in medical dermatology, the company said.
Dermatology 52
52 
Is this a novel and disruptive approach to immuno-dermatology?
Drug Discovery World
MARCH 23, 2023
Aldena Therapeutics, a biotech company that is pioneering siRNA-based therapies for dermatological indications, has updated its immuno-dermatology pipeline, appointed a Scientific Advisory Board (SAB), and announced $30 million financing by Medicxi. appeared first on Drug Discovery World (DDW).
Dermatology 52
52 
Almirall announces a new research collaboration with the University of Dundee to develop an innovative and differentiated treatment approach for dermatological diseases
Pharma Mirror
APRIL 8, 2022
BARCELONA, Spain and Dundee, UK, a global biopharmaceutical company focused on skin health, today announced a research collaboration with the University of Dundee, a top-ranked university in the UK in biological sciences, to develop a novel approach against chronic and debilitating dermatology diseases where itch, or pruritus, plays a dominant role.
Dermatology 130
130 
Dermatology program brings timely and accurate diagnosis of skin conditions to underserved communities
Medical Xpress
JANUARY 24, 2023
A dermatology program first developed by the University of Missouri in 2015 can bring life-saving diagnoses of skin conditions to communities without adequate dermatologic care.
Dermatology 75
75 
Fishawack Health welcomes expert-led dermatology initiative FIDE to its group
pharmaphorum
NOVEMBER 11, 2021
KNUTSFORD, United Kingdom — Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology. Kenneth B Gordon, MD, Professor and Chair of Dermatology at the Medical College of Wisconsin. November 10, 2021, UK.
Dermatology 98
98 
FDA approves new vitiligo treatment, bolstering Incyte's dermatology business
Bio Pharma Dive
JULY 19, 2022
The cream, known as Opzelura, is now the only treatment approved in the U.S. to repigment skin in patients with the most common form of vitiligo.
FDA Approval 337
337 
Google Launches AI-Based Dermatology Assist Tool
XTalks
MAY 26, 2021
Google has developed an AI-powered dermatology assist tool designed to detect conditions of the skin, hair and nails based on phone images taken by the user. The tool allows users to identify dermatologic issues such as a rash on the arm or nail discoloration using a phone camera. Development of the AI Dermatology Health Tool.
Dermatology 98
98 
4th Dermatology Drug Development Summit Europe
pharmaphorum
MAY 9, 2023
4th Dermatology Drug Development Summit Europe Mike.Hammerton Tue, 05/09/2023 - 20:11 Bookmark this
Dermatology 52
52 
LEO partners with ICON to offer patient-centric dermatology trials
Drug Discovery World
MARCH 13, 2023
LEO Pharma and ICON have formed a strategic partnership that will enable LEO to offer clinical trials within medical dermatology that are patient-centric and cost effective. The post LEO partners with ICON to offer patient-centric dermatology trials appeared first on Drug Discovery World (DDW).
Dermatology 52
52 
Incyte, branching out in dermatology, to buy startup Villaris
Bio Pharma Dive
OCTOBER 4, 2022
The acquisition, Incyte’s first of an entire company, hands the pharmaceutical company a potentially long lasting treatment for the skin disease vitiligo.
Dermatology 233
233 Dermatology 233
233 
Animated and Live Action Content Delivers Precise Training for Dermatology Studies
WCG Clinical
MARCH 30, 2023
Uniform Live Action Training Using InvestigatorSpace Speeds Up Study Start Times In one case, a global pharmaceutical company used WCG’s training solutions to support two dermatology studies they were running.
Dermatology 52
52 
Dermatology drug developer taps into Veeva engagement tool
Outsourcing Pharma
MAY 23, 2022
With Veeva Link for Key People, LEO Pharma is looking to deepen its efforts to engage with knowledgeable medical professionals in the dermatology community.
Dermatology 52
52 
Castle Biosciences Presents Data from Suite of Dermatologic Cancer Genomic Tests at Fall Clinical Dermatology Conference 2021
BioTech 365
OCTOBER 22, 2021
Castle Biosciences Presents Data from Suite of Dermatologic Cancer Genomic Tests at Fall Clinical Dermatology Conference 2021 Castle Biosciences Presents Data from Suite of Dermatologic Cancer Genomic Tests at Fall Clinical Dermatology Conference 2021 The Company also highlights the study … Continue reading →
Dermatology 52
52 
Google’s AI Dermatology App + WHO’s Investigations into Coronavirus Lab Leak Theory
XTalks
JUNE 2, 2021
In this episode, Ayesha talks about Google’s new AI-based dermatology tool designed to help people identify and research conditions of the skin, hair and nails. Read the full articles here: Google Launches AI-Based Dermatology Assist Tool. WHO Calls for Probe into SARS-CoV-2 Origins as Lab Leak Theories Intensify.
Dermatology 59
59 
Torrent Pharma to acquire Curatio for $245.16m
Pharmaceutical Technology
SEPTEMBER 29, 2022
The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Holding a presence in the cosmetic dermatology sector, Curatio’s portfolio comprises more than over 50 brands that are commercialised in India. The portfolio includes brands such as Tedibar, Atogla, Spoo, B4 Nappi and Permite.
Dermatology 147
147 
Sun Pharma to buy Concert Pharmaceuticals for $576m
Pharmaceutical Technology
JANUARY 19, 2023
Concert’s patent portfolio includes oral Janus kinases JAK1/2 inhibitor, deuruxolitinib, to treat Alopecia Areata, an autoimmune dermatological disease. The company also noted that the deal will strengthen its global dermatology franchise with the addition of a late-stage product in an area with significant unmet need.
Dermatology 147
147 
Melanoma Research Alliance Announces 13 Dermatology Fellowship Award Recipients
BioTech 365
JULY 8, 2021
Melanoma Research Alliance Announces 13 Dermatology Fellowship Award Recipients Melanoma Research Alliance Announces 13 Dermatology Fellowship Award Recipients Initiative Represents MRAs Largest Investment in Prevention and Early Detection WASHINGTON–(BUSINESS WIRE)–The Melanoma Research Alliance, the largest non-profit funder of melanoma (..)
Dermatology 52
52 
Almirall analyses wider well-being in dermatology study
Pharma Times
APRIL 12, 2023
The trial will monitor patients across Europe for 24 months as they are treated with tildrakizumab
Dermatology 118
118 
Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference
BioTech 365
JANUARY 14, 2022
Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference DURHAM, N.C., 14, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the the Company” or “Novan”) … Continue reading →
Dermatology 40
40 Dermatology 40
40 
Dr. Ellen Turner’s Dermatology Office Celebrates Launch of Audrose Beauty Collection with Vogue100
BioTech 365
DECEMBER 29, 2021
Ellen Turner’s Dermatology Office Celebrates Launch of Audrose Beauty Collection with Vogue100 Dr. Ellen Turner’s Dermatology Office Celebrates Launch of Audrose Beauty Collection with Vogue100 The Dallas-based Skin Care Team Joined Audrose™ Founder Justine Nichole for an Exclusive December … Continue reading →
Dermatology 40
40 Dermatology 40
40 
Verrica’s Dr. Lawrence Eichenfield Speaks About FDA Approval of New Drug for Common Skin Infection – Xtalks Life Science Podcast Ep. 121
XTalks
AUGUST 2, 2023
Verrica Pharmaceuticals is a dermatology therapeutics company developing medications for skin diseases that require medical interventions. Tune into this episode to learn more about YCANTH and its approval, as well as the changing landscape of dermatology, from Dr. Eichenfield.
FDA Approval 52
52 
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit
BioTech 365
MAY 10, 2021
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit LA JOLLA, Calif.–(BUSINESS –(BUSINESS WIRE)–DermTech, Inc.
Dermatology 52
52 Dermatology 52
52 
DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021
BioTech 365
JANUARY 19, 2021
DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021 DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021 LA JOLLA, Calif.–(BUSINESS NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin … Continue reading →
Dermatology 52
52 Dermatology 52
52 
#news #biotech Leo taps X-Chem to discover anti-inflammatory dermatology drugs
BioTech 365
JULY 6, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Leo taps X-Chem to discover anti-inflammatory dermatology drugs.Leo taps X-Chem to discover anti-inflammatory dermatology drugs ntaylor Tue, 07/06/2021 – 07:16 from FierceBiotech: Biotech [link].
Dermatology 40
40 
Castle Biosciences Presents Data at the Dermatology Nurses’ Association 2021 Annual Convention
BioTech 365
APRIL 22, 2021
Castle Biosciences Presents Data at the Dermatology Nurses’ Association 2021 Annual Convention Castle Biosciences Presents Data at the Dermatology Nurses’ Association 2021 Annual Convention FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #DNANurses–Castle Biosciences, Inc.
Dermatology 40
40 
MedX and PharmaChoice team up for teledermatology screening service
Pharmaceutical Technology
APRIL 19, 2023
In Canada, access to dermatological care is extremely limited, with only 1.7 In Canada, access to dermatological care is extremely limited, with only 1.7 A dermatologist is then able to review the data and provide a course of action. “In
Dermatology 130
130 
Hers Introduces New Prescription Dermatology Offerings Increasing Support for Women Experiencing Common Yet Emotionally Distressing Hair Loss
BioTech 365
JANUARY 13, 2022
Hers Introduces New Prescription Dermatology Offerings Increasing Support for Women Experiencing Common Yet Emotionally Distressing Hair Loss Hers Introduces New Prescription Dermatology Offerings Increasing Support for Women Experiencing Common Yet Emotionally Distressing Hair Loss Topical Finasteride & Minoxidil Spray and … Continue reading (..)
Dermatology 52
52 Dermatology 52
52 
US FDA accepts Arcutis’ NDA for seborrheic dermatitis therapy
Pharmaceutical Technology
APRIL 19, 2023
“If approved, roflumilast foam would be the first topical drug with a new mechanism of action for this condition in over two decades, highlighting the unique formulation and deep dermatological expertise that Arcutis brings to immuno-dermatology.” in patients with seborrheic dermatitis.
Dermatology 130
130 
DermTech Presents Updates in Precision Medicine at 2020 Dermatology Drug Development Summit
BioTech 365
DECEMBER 3, 2020
DermTech Presents Updates in Precision Medicine at 2020 Dermatology Drug Development Summit DermTech Presents Updates in Precision Medicine at 2020 Dermatology Drug Development Summit LA JOLLA, Calif.–(BUSINESS –(BUSINESS WIRE)–DermTech, Inc.
Dermatology 52
52 
Pyramid Biosciences Announces First Patients Dosed in Phase 1 Clinical Program for Dermatology
BioTech 365
MAY 20, 2021
Pyramid Biosciences Announces First Patients Dosed in Phase 1 Clinical Program for Dermatology Pyramid Biosciences Announces First Patients Dosed in Phase 1 Clinical Program for Dermatology PBI-100 is a topical treatment being developed for people living with mild to moderate … Continue reading →
Dermatology 52
52 
DermTech Presents New Clinical Research Abstract at the 2020 Fall Clinical Dermatology Conference
BioTech 365
NOVEMBER 17, 2020
DermTech Presents New Clinical Research Abstract at the 2020 Fall Clinical Dermatology Conference DermTech Presents New Clinical Research Abstract at the 2020 Fall Clinical Dermatology Conference LA JOLLA, Calif.–(BUSINESS –(BUSINESS WIRE)–DermTech, Inc.
Dermatology 52
52 
Dermatology Drugs Market Research Report 2020 – Global Industry Analysis and Growth Forecast to 2030 – ResearchAndMarkets.com
BioTech 365
MARCH 15, 2021
Dermatology Drugs Market Research Report 2020 – Global Industry Analysis and Growth Forecast to 2030 – ResearchAndMarkets.com Dermatology Drugs Market Research Report 2020 – Global Industry Analysis and Growth Forecast to 2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Dermatology Drugs Market Research (..)
Dermatology 40
40 
Castle Biosciences to Present Data at the 2021 American Academy of Dermatology (AAD) Summer Meeting
BioTech 365
AUGUST 6, 2021
Castle Biosciences to Present Data at the 2021 American Academy of Dermatology (AAD) Summer Meeting Castle Biosciences to Present Data at the 2021 American Academy of Dermatology (AAD) Summer Meeting Oral presentations to highlight DecisionDx®-Melanoma and DecisionDx®-SCC FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL … Continue reading (..)
Dermatology 52
52 Dermatology 52
52 Global Dermatology, Gastroenterology and Rheumatology Practices 2021 and the Impact of COVID-19 – ResearchAndMarkets.com
BioTech 365
FEBRUARY 17, 2021
Global Dermatology, Gastroenterology and Rheumatology Practices 2021 and the Impact of COVID-19 – ResearchAndMarkets.com Global Dermatology, Gastroenterology and Rheumatology Practices 2021 and the Impact of COVID-19 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Coronavirus Disease 2019 (COVID-19) Impact on the (..)
Dermatology 40
40 
Multiple Abstracts from Incyte’s Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experience
BioTech 365
APRIL 20, 2021
Multiple Abstracts from Incyte’s Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experience Multiple Abstracts from Incyte’s Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experience More than 14 abstracts, including new findings from Incyte’s clinical … Continue reading →
Dermatology 52
52 Dermatology 52
52 Castle Biosciences’ Full DecisionDx® Portfolio of Dermatologic Tests to Be Interfaced with EMA® Electronic Health Records System
BioTech 365
NOVEMBER 4, 2021
Castle Biosciences’ Full DecisionDx® Portfolio of Dermatologic Tests to Be Interfaced with EMA® Electronic Health Records System Castle Biosciences’ Full DecisionDx® Portfolio of Dermatologic Tests to Be Interfaced with EMA® Electronic Health Records System Interface facilitates ease of ordering within … Continue reading →
Dermatology 52
52 Dermatology 52
52 
Cancer may lurk in 'normal looking' skin
Medical Xpress
MAY 11, 2023
Researchers from UQ's Frazer Institute Dermatology Research Center investigated the relationship between the number of mutations found in 'normal looking' skin and the number of a person's past skin cancers.
Dermatology 126
126 Mary Kay Unveils Skin Health Grants, Breakthrough Retinol Research at 2021 Society for Investigative Dermatology Conference
BioTech 365
MAY 10, 2021
Mary Kay Unveils Skin Health Grants, Breakthrough Retinol Research at 2021 Society for Investigative Dermatology Conference Mary Kay Unveils Skin Health Grants, Breakthrough Retinol Research at 2021 Society for Investigative Dermatology Conference DALLAS–(BUSINESS WIRE)–Mary Kay Inc.,
Dermatology 52
52 
Treatment options for Crohn’s disease expand after Rinvoq approval
Pharmaceutical Technology
MAY 19, 2023
The FDA nod means Rinvoq is now approved for seven indications in gastroenterology, rheumatology and dermatology. A maintenance study showed the same effects at 52 weeks. Clinical response was observed after just two weeks in some cases.
FDA Approval 264
264 
Follica Announces Poster Presentation Demonstrating Unmet Treatment Needs in Androgenetic Alopecia at 2022 Winter Clinical Dermatology Conference and 2022 Maui Derm Meeting
BioTech 365
JANUARY 19, 2022
Follica Announces Poster Presentation Demonstrating Unmet Treatment Needs in Androgenetic Alopecia at 2022 Winter Clinical Dermatology Conference and 2022 Maui Derm Meeting Follica Announces Poster Presentation Demonstrating Unmet Treatment Needs in Androgenetic Alopecia at 2022 Winter Clinical Dermatology Conference and … Continue reading → (..)
Dermatology 52
52 Dermatology 52
52 Galderma to Acquire Award-winning ALASTIN Skincare® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients
BioTech 365
NOVEMBER 29, 2021
Galderma to Acquire Award-winning ALASTIN Skincare® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients Galderma to Acquire Award-winning ALASTIN Skincare® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients ALASTIN Skincare® … Continue reading → (..)
Dermatology 52
52 Dermatology 52
52 
Let's personalize your content